Companies discussed: Biogen Inc (NASDAQ:BIIB), Sarepta Therapeutics Inc (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Biogen First up, Biogen Inc (NASDAQ:BIIB). Biogen is a little larger than our normal focus range market capitalization here at Small Cap Exclusive, but it’s making waves in the biotech space on the back of some trial data,...
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares rose to $19.67 as of the market close on Tuesday but retreated by 0.10% to $19.65 in after hours trading. The company recently got a request from the FDA for dystrophin data before making a decision on the eteplirsen NDA. A few months back, Sarpeta Therapeutics shares...
LDR Holding Corp (NASDAQ:LDRH) shares scored an additional 0.05% to $37.01 in after hours trading, underscoring the strong bullish momentum. The company received an acquisition offer from Zimmer Biomet Holdings to the tune of $1 billion in cash. This puts the share value of LDR Holding Corp at $37, representing...
Companies discussed: GlycoMimetics Inc (NASDAQ:GLYC), Cara Therapeutics Inc (NASDAQ:CARA), Advaxis, Inc (NASDAQ:ADXS) GlycoMimetics First up, GlycoMimetics Inc (NASDAQ:GLYC). GlycoMimetics just kicked off a phase 2 trial in patient with relapsed/refractory acute myeloid leukemia. The trial is the second part of a phase 1/2 in its lead oncology candidate, GMI1271, investigating the drug in combination...
Minerva Neurosciences Inc (NASDAQ:NERV) shares jumped 13.09% on June 1 to $13.91 after the company shared positive top-line results in clinical trials for its antidepressant drug candidate. Minerva Neurosciences Inc (NASDAQ:NERV) is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of a portfolio of product candidates to treat...